Page 97 - Biomarkers for risk stratification and guidance in heart failure
P. 97
Chapter 4
Funding
No funding was received specific to the meta-analysis. Funding related to the original studies included in the meta-analysis is provided elsewhere.1
Conflict of interest:
H-P.B.LR. received unrestricted grant support and honoraria from Roche Diagnostics. L.E. received consultancy fees from Roche Diagnostics. M.R. received honoraria, travel grants, and research grants from Roche Diagnostics and Alere. J.J. received grant support from Siemens, Brahms, and Singulex. consultancy fees from Roche Diagnostics, Sphingotec, Critical Diagnostics. U.D. received consultancy fees from Vifor Pharma, Alere, and Novartis, honoraria from Roche Diagnostics and unrestricted grant support from Astra Zeneca. H.G. received honoraria or consultancy fees from Roche Diagnostics, Critical Diagnostics, and Luitpold Pharmaceuticals. C.O’C. received institutional grant support from Roche Diagnostics. R.T. received grant support and honoraria from Roche Diagnostics and St Jude Medical. The remaining authors report no conflicts of interest.
96
